🔴 Ionis Pharmaceuticals is trading 4.2% down in pre-market — no clear company-specific catalyst identified

Ionis Pharmaceuticals is trading 4.2% down at $58.75 after closing at $61.33 on September 2, 2026; no clear company-specific catalyst was identified.

• Ionis announced investor-conference appearances on September 3, but the routine update does not explain the decline.
• Nasdaq futures were down 0.27% amid mixed broader futures, but the market move was not strong enough to establish a clear global cause.